Beyond the PML-RARα, APL is characterized by a limited spectrum of recurrent mutations—primarily FLT3, WT1, NRAS, and KRAS—and a near absence of mutations common in other AML subtypes [61]. This evidence concerns the gene FLT3 and acute promyelocytic leukemia.